NEW YORK (GenomeWeb News) – ChromoTek today announced it has signed a contract with Bulldog Bio to distribute ChromoTek's entire line of affinity reagents in the US and Canada.

Portsmouth, NH-based Bulldog will sell and support ChromoTek's line of novel tools for protein and cell biology. Financial and other terms were not disclosed.

ChromoTek is based in Planegg-Martinsried, Germany and offers immunologic research tools derived from single domain alpaca antibodies for cell biology and proteomics. The company is a spinout of the Ludwig-Maximilians University Munich.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.